Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
* Four products recalled; over-the-counter ones not affected* UK regulator says recall a "precautionary measure"* Regulators investigating ranitidine drugs for impurities (Adds details on products affected, context on other drugmakers halting suppl...
Read more(Adds context on U.S. FDA move)Oct 8 (Reuters) - GlaxoSmithKline Plc is recalling its heartburn medicine Zantac as a "precautionary measure" due to a probable cancer-causing impurity in the drug, Britain's medicines watchdog said on Tuesday.The mo...
Read more
Drug Alert As GlazoSmithKline Recalls Zantac; Collaboration Launched
Read moreOct 8 (Reuters) - GlaxoSmithKline Plc is recalling its heartburn medicine Zantac as a "precautionary measure" due to a probable cancer-causing impurity in the drug, Britain's medicines watchdog said on Tuesday.GSK is recalling all unexpired stock ...
Read more* FTSE 100 up 0.6%, FTSE 250 dips 0.3%* Hopes for U.S.-China deal help blue-chips* Mid-cap SIG plummets after profit warning (Adds company news items, updates share moves)By Muvija M and Shashwat AwasthiOct 7 (Reuters) - Oil majors led a rebound in ...
Read more(Adds comment from GSK spokesman)Oct 4 (Reuters) - Vectura Group said on Friday a British court had ruled in its favour on the packaging of a generic version of an inhaler made by bigger rival GlaxoSmithKline.Vectura said the court dismissed all G...
Read moreHigh Court Dismisses Glaxo Case Against Generic Seretide Accuhaler
Read moreOct 4 (Reuters) - British drugmaker AstraZeneca said on Friday that the U.S. Food and Drug Administration (FDA) has approved self-administration of its asthma treatment Fasenra which uses a pre-filled, single-use auto-injector pen.The move is a bo...
Read more(Adds details on treatment, context and background)Oct 1 (Reuters) - The U.S. Food and Drug Administration declined to approve AstraZeneca Plc's combination therapy to treat smoker's lung, the drugmaker said on Tuesday.AstraZeneca said that it will...
Read more* European end higher after choppy, low-volumes session * STOXX 600 +3.6% in Sept, marks 3rd positive quarter in a row * JPM raises euro-zone stocks to "overweight" * ECB's Draghi emphasises need for fiscal push - FT * Wall St...
Read moreBy Ludwig BurgerBARCELONA, Sept 30 (Reuters) - AstraZeneca presented results on Monday for a trial of its Lynparza drug against prostate cancer, which it hopes could lead to wider regulatory approval for the treatment for use against more forms of...
Read more* European shares tread water * STOXX 600 up 0.2% after slightly negative start * Volumes below average * JPM raises euro-zone stocks to "overweight" * ECB's Draghi emphasises need for fiscal push * Wall Street opens high...
Read more* European shares tread water * STOXX 600 flat after slightly negative start * JPM raises euro-zone stocks to "overweight" * ECB's Draghi emphasises need for fiscal push * Asian shares mostly flat Welcome to the home for re...
Read moreWINNERS & LOSERS SUMMARY: Whitbread Hit By Barclays Downgrade
Read more
Last checked at